Expression of p53 protein and prognosis in gastric carcinoma

dc.contributor.buuauthorGürel, Selim
dc.contributor.buuauthorDolar, Mahmut Enver
dc.contributor.buuauthorYerci, Ömer
dc.contributor.buuauthorSamlı, Bülent
dc.contributor.buuauthorÖztürk, Hülya
dc.contributor.buuauthorNak, Selim Giray
dc.contributor.buuauthorGülten, Macit
dc.contributor.buuauthorMemik, Faruk
dc.contributor.departmentUludağ Üniversitesi/Tıp fakültesi/Gastroenteroloji Anabilim Dalı.tr_TR
dc.contributor.departmentUludağ Üniversitesi/Tıp Fakültesi/Patoloji Anabilim Dalı.tr_TR
dc.contributor.researcheridAAG-9177-2021tr_TR
dc.date.accessioned2021-08-18T07:27:24Z
dc.date.available2021-08-18T07:27:24Z
dc.date.issued1999
dc.description.abstractA study was carried out to assess whether p53 expression is related to tumour type, grade or pathological characteristics, or to prognosis, in gastric cancer. Immunohistochemical studies were performed to detect p53 protein in sections from 55 consecutive gastrectomy or partial gastrectomy specimens. Tumours were classified for T-stage, histopathological grade and pathological characteristics. Immunohistochemical staining detected p53 protein in 11 (19%) of the 55 specimens. There was no statistically significant difference between patients with p53 positively staining tumours and patients with p53 negatively staining tumours with regard to tumour grade, stage or pathological characteristics (lymph-node infiltration, depth of invasion, necrosis, or necrosis of vessels). Survival time was statistically significantly lower in patients with positively staining tumours (mean survival times 12.0 and 23.4 months, respectively). These results suggest that expression of p53 protein is related to poor prognosis in gastric carcinoma.en_US
dc.identifier.citationGürel, S. vd. (1999). "Expression of p53 protein and prognosis in gastric carcinoma". Journal of International Medical Research, 27(2), 85-89.en_US
dc.identifier.endpage89tr_TR
dc.identifier.issn0300-0605
dc.identifier.issue2tr_TR
dc.identifier.pubmed10446695tr_TR
dc.identifier.scopus2-s2.0-0344348911&tr_TR
dc.identifier.startpage85tr_TR
dc.identifier.urihttps://journals.sagepub.com/doi/10.1177/030006059902700205
dc.identifier.urihttp://hdl.handle.net/11452/21455
dc.identifier.volume27tr_TR
dc.identifier.wos000081397900005tr_TR
dc.indexed.pubmedPubmeden_US
dc.indexed.scopusScopusen_US
dc.indexed.wosSCIEen_US
dc.language.isoenen_US
dc.publisherCambridge Med Publen_US
dc.relation.journalJournal of International Medical Researchen_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergitr_TR
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectResearch & experimental medicineen_US
dc.subjectPharmacology & pharmacyen_US
dc.subjectP53 proteinen_US
dc.subjectGastric carcinomaen_US
dc.subjectClinicopathological featuresen_US
dc.subjectPrognosisen_US
dc.subject.scopusMicrosatellite Instability; Stomach Neoplasms; Endoscopic Mucosal Resectionen_US
dc.subject.wosMedicine, research & experimentalen_US
dc.subject.wosPharmacology & pharmacyen_US
dc.titleExpression of p53 protein and prognosis in gastric carcinomaen_US
dc.typeArticle
dc.wos.quartileQ4 (Pharmacology & pharmacy)en_US
dc.wos.quartileQ3 (Medicine, research & experimental)en_US

Files

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
030006059902700205.pdf
Size:
959.26 KB
Format:
Adobe Portable Document Format
Description:

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description: